Bottom line
AEYXX vs EMOP: the short answer
AEYXX (AB Government Money Market Portfolio) and EMOP (AB Emerging Markets Opportunities ETF) are both money market funds.
AEYXX is cheaper at 0.24% vs 0.7% — a difference of $46 a year per $10,000 invested.
Over five years, EMOP returned +4.6% a year vs +3.1% for AEYXX.
Updated Nov 19, 2026
AEYXX vs EMOP side by side
| AEYXX | EMOP | |
|---|---|---|
| Type | Money market fund | ETF |
| Fund family | Ab Fixed Income Shares | Ab Active Etfs |
| Category | Money Market | Emerging Markets |
| Expense ratio | 0.24% | 0.7% |
| Annual cost per $10k | $24 | $70 |
| 10-yr cost on $10k (prospectus) | $306 | — |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +4.1% | +30.7% |
| 5-yr return (annualized) | +3.1% | +4.6% |
| 10-yr return (annualized) | +2.1% | +7.4% |
| Best quarter | — | +21.9% |
| Worst quarter | — | −25.9% |
| Net assets (fund) | — | $2.1B |
| Number of holdings | — | 57 |
| Portfolio turnover | — | 79% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
AEYXX and EMOP share none of their top holdings.
AEYXX top 10
EMOP top 10
- Taiwan Semiconductor Manufacturing Co Ltd — 17.14%
- Samsung Electronics Co Ltd — 10.63%
- SK hynix Inc — 8.10%
- ICICI Bank Ltd — 3.39%
- Delta Electronics Inc — 3.03%
- Fomento Economico Mexicano SAB de CV — 2.87%
- China Merchants Bank Co Ltd — 2.64%
- Petroleo Brasileiro SA - Petrobras — 2.63%
- Dr Reddy's Laboratories Ltd — 2.54%
- Colgate-Palmolive Co — 2.53%
FAQ
What is the difference between AEYXX and EMOP?
AEYXX (AB Government Money Market Portfolio) and EMOP (AB Emerging Markets Opportunities ETF) are both money market funds. AEYXX is cheaper at 0.24% vs 0.7% — a difference of $46 a year per $10,000 invested.
Which is cheaper, AEYXX or EMOP?
AEYXX has the lower expense ratio (0.24%).
Should I own both AEYXX and EMOP?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.